Posted on December 1, 2007 by Ramesh Verma
Aethlon Medical, Inc. disclosed that it has filed a provisional patent entitled, “Affinity Capture of Circulating Cancer Biomarkers,” with the U.S. Patent and Trademark Office (USPTO). The patent describes the use of the Aethlon Hemopurifier® as a device that fills the unmet need of identifying circulating cancer biomarkers to assist in early detection of cancer, [...]
Filed under: Uncategorized | Leave a Comment »
Posted on December 1, 2007 by Ramesh Verma
Oncolytics Biotech Inc. has announced that he has been awarded with the grant of U.S. Patent 7,300,650 entitled “Reovirus for the Treatment of Neoplasia.” The claims describe methods of using the reovirus to treat cancers that have inactivated PKR, whether the PKR is inactivated by mutation of Ras or by other factors. PKR is a [...]
Filed under: Uncategorized | Leave a Comment »
Posted on December 1, 2007 by Ramesh Verma
The United States (US) Food and Drug Administration (FDA) has granted an additional six month period of exclusivity to market ARIMIDEX® (anastrozole) for its licensed breast cancer indications until June 2010 to AstraZeneca. Prior to paediatric exclusivity being granted by the FDA, the patent was due to expire in December 2009.
In the US, ARIMIDEX sales [...]
Filed under: Uncategorized | Leave a Comment »
Posted on December 1, 2007 by Ramesh Verma
Chem-spider is “an online resource for chemists to search, aggregate and data mine publicly available chemical data. ChemSpider has released the Beta version which offers numerous tools of general value to chemists. It allows you to search a chemical database containing millions of chemical structures and various associated property information. The searches can be based [...]
Filed under: Uncategorized | Leave a Comment »